1-(2-Acetylamino-3-hydroxy-propionyl)-pyrrolidine-2-carboxylic acid {1-[1-(1-carbamoyl-2-hydroxy-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-phenyl-ethyl}-amide

ID: ALA321718

PubChem CID: 14999610

Max Phase: Preclinical

Molecular Formula: C28H43N9O8

Molecular Weight: 633.71

Molecule Type: Protein

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(N)=O

Standard InChI:  InChI=1S/C28H43N9O8/c1-16(40)33-21(15-39)27(45)37-12-6-10-22(37)26(44)35-19(13-17-7-3-2-4-8-17)25(43)34-18(9-5-11-32-28(30)31)24(42)36-20(14-38)23(29)41/h2-4,7-8,18-22,38-39H,5-6,9-15H2,1H3,(H2,29,41)(H,33,40)(H,34,43)(H,35,44)(H,36,42)(H4,30,31,32)/t18-,19-,20-,21-,22-/m0/s1

Standard InChI Key:  MZNNHWHLAUCULO-YFNVTMOMSA-N

Molfile:  

     RDKit          2D

 45 46  0  0  1  0  0  0  0  0999 V2000
   -1.6000   -3.5750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0208   -2.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1500   -3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5875   -2.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8583   -3.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9625   -3.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0792   -3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7792   -3.9042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5542   -3.9042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4875   -3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6667   -3.5000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2542   -3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1917   -3.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0500   -1.4292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7792   -7.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3667   -3.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8708   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4875   -7.5667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7708   -2.8500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1708   -2.6417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9625   -4.7167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0792   -2.6792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2542   -2.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1917   -4.7167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3458   -0.8167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7792   -6.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0792   -7.5667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8917   -3.5000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1458   -4.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7750   -2.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6667   -1.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4875   -2.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9458   -4.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583   -1.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1917   -2.2792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7375   -4.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2250   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3667   -4.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0792   -5.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4917   -1.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2417   -1.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0792   -5.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -0.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9000   -1.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4792   -0.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  5  3  1  6
  4  2  1  0
  5  1  1  0
  6 12  1  0
  7 16  1  0
  8  7  1  0
  9  3  1  0
 10  8  1  1
 11  6  1  0
 12  9  1  1
 13 10  1  0
  4 14  1  1
 15 26  2  0
 16 11  1  6
 17 14  1  0
 18 15  1  0
 19  2  2  0
 20  3  2  0
 21  6  2  0
 22  7  2  0
 12 23  1  0
 24 13  2  0
 25 17  2  0
 26 39  1  0
 27 15  1  0
 28 13  1  0
 29  1  1  0
  4 30  1  0
 31 23  1  0
 10 32  1  0
  5 33  1  0
 34 30  1  0
 35 32  1  0
 36 29  1  0
 37 17  1  0
 16 38  1  0
 39 42  1  0
 40 31  2  0
 41 31  1  0
 42 38  1  0
 43 41  2  0
 44 40  1  0
 45 43  1  0
 36 33  1  0
 44 45  2  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(non-human)

Kallikrein 1 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 633.71Molecular Weight (Monoisotopic): 633.3235AlogP: -4.30#Rotatable Bonds: 17
Polar Surface Area: 284.66Molecular Species: BASEHBA: 9HBD: 9
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.67CX Basic pKa: 10.77CX LogP: -5.12CX LogD: -7.21
Aromatic Rings: 1Heavy Atoms: 45QED Weighted: 0.05Np Likeness Score: 0.11

References

1. Deshpande MS, Burton J..  (1992)  Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392.,  35  (17): [PMID:1507198] [10.1021/jm00095a002]

Source